TRI 0.00% 1.8¢ trivarx ltd

Ann: FDA Strategy and Regulatory Update, page-331

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 667 Posts.
    lightbulb Created with Sketch. 205
    If you have held till now, I encourage you to hold for a few more weeks. I expect to see a few updates in the coming weeks.

    1. FDA 501k approval for MEBsleep

    Substantive review start = 24/08/2020
    45day timeline = 08/10/2020
    I suspect the company is providing answers to queries from the reviewer and an ANN that the application has been accepted for Interactive review (30day review) or that application is approved may be released soon-ish. I understand the Interactive review could be a series of phone calls and correspondences to provide some clarifications.

    2. CE Mark application for MEBsleep

    30/08/2020 - Technical file for MEBsleep submitted (Step 5 below)
    https://hotcopper.com.au/data/attachments/2586/2586909-dadb1633665347be4f716f196170e841.jpg
    3. MEB001 FDA Breathrough Device Designation (60day process)

    Submitted application = 02/10/2020
    Approval = 01/12/2020

    4. Other Anns regarding Ilumen and software app development.

    At MCAP of about $16m, it's not impossible to trading at $64m by Christmas based on peer review. Am I missing something here?

    DYOR
 
watchlist Created with Sketch. Add TRI (ASX) to my watchlist
(20min delay)
Last
1.8¢
Change
0.000(0.00%)
Mkt cap ! $8.226M
Open High Low Value Volume
1.9¢ 1.9¢ 1.7¢ $16.41K 912.7K

Buyers (Bids)

No. Vol. Price($)
9 1157999 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.8¢ 58353 2
View Market Depth
Last trade - 12.53pm 13/11/2024 (20 minute delay) ?
TRI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.